Discover a study revealing how seborrheic dermatitis is linked to multiple epithelial barrier diseases, supporting the ...

Hot off its first approval this summer in psoriasis, Arcutis Biotherapeutics’ roflumilast foam 0.3%, approved in cream form under the brand name Zoryve, is out to prove it’s no one-trick pony in itch.

Seborrheic dermatitis is linked to other epithelial barrier diseases, supporting the epithelial barrier theory as a shared ...

There are a few ingredients that can help treat dry patches. “I advise patients to look for products that contain hyaluronic ...

Researchers at the Perelman School of Medicine at the University of Pennsylvania report that adults with seborrheic ...

A large U.S. study links seborrheic dermatitis to psoriasis, rosacea, and other barrier diseases, supporting the epithelial ...

First FDA-approved medication for atopic dermatitis (eczema), plaque psoriasis, and seborrheic dermatitis to win prominent “Breakthrough Award” ZORYVE is the number one prescribed branded topical ...

Seborrheic dermatitis may be linked to various epithelial barrier diseases (EBDs) affecting multiple organ systems and ultimately a key factor when addressing epithelial barrier weakness and ...